Iron deficiency anemia among kindergarten children living in the marginalized areas of Gaza Strip, Palestine

Abstract

Background:

iron deficiency anemia is the most common type of nutritional anemia; it has been recognized as an important health problem in Palestine. This study was conducted to estimate the prevalence and to identify possible risk factors of iron deficiency anemia among kindergarten children living in the marginalized areas of the Gaza Strip and to evaluate the effectiveness of supplementing oral iron formula in the anemic children.

Methods:

the study included 735 (384 male and 351 female) kindergarten children. Data was collected by questionnaire interviews, anthropometric measurements, and complete blood count analysis. All iron deficient anemic children were treated using an oral iron formula (50 mg ferrous carbonate + 100 mg vitamin C /5 mL) and the complete blood count was reassessed after three months. A univariate analysis and a multiple logistic regression model were constructed; crude and adjusted odds ratios (OR), and 95% confidence intervals (95% CI) were calculated.

Results:

the overall prevalence of iron deficiency anemia was 33.5% with no significant differences between boys and girls. Significantly different prevalences of iron deficiency anemia were reported between different governorates of the Gaza Strip. Governorate, low education level of the parents and smoking are significant risk factors for children developing anemia. Significantly lower complete blood count parameters, except for WBC, were reported in anemic children. The oral iron treatment significantly improved hemoglobin concentrations, and normalized the iron deficiency marker.

Conclusions:

iron deficiency anemia is a serious health problem among children living in the marginalized areas of the Gaza Strip, which justifies the necessity for national intervention programs to improve the health status for the less fortunate development areas.

Anemia; Iron deficiency; Microcystis; Ferrous compounds

Introduction

Anemia due to iron deficiency is the most common and widespread nutritional anemia in the world and significantly afflicts individuals of all ages and economic groups in both developing and developed countries. Iron deficiency and its associated anemia are more common among the very young, among those on poor diets, among people with intestinal parasitic diseases, and among women of childbearing age. The World Health Organization (WHO) estimates are staggering; almost one-third (more than 2 billion people) of the world's population are anemic, most of which is due to iron deficiency.^1,2

Although the prevalence of iron deficiency anemia (IDA) in industrialized countries has declined in recent decades, there has been little effect on in the global prevalence, which remains high and challenging. In developing countries, the WHO expects more troubling prevalences reporting that one in two pregnant women and about 40% of preschool children are likely to be anemic, many of them due to iron deficiency. This condition is intensified and exacerbated by parasites, malaria and other infectious diseases such as HIV and tuberculosis, especially in resource-poor and underdeveloped areas.^3,4 In addition to nutritional and clinical factors, several studies associate socioeconomic factors, such as low parental education levels, low household incomes,^5,6 and demographic factors including age, gender, and family size^3,7 to the prevalence and worsening of anemia.

Poor pregnancy outcomes, maternal deaths, impaired physical and cognitive development, increased risk of morbidity in children and reduced work productivity in adults are major health concerns and clinical manifestations associated with anemia.^8,10 As anemia worsens, multiple cardiovascular signs generally start to appear, beginning with tachycardia, palpitations, impaired ventricular performance, cardiomegaly, and sometimes cardiac arrhythmia and congestive heart failure. Furthermore, red blood cells of anemic subjects are more vulnerable to oxidation, concomitant to increased lipid peroxidation and diminished antioxidant defense and enzymes.¹¹ On the national economical level, IDA lowers the work capacity, causing serious economic difficulties and obstacles to national development strategic plans.^12-14

Treatment of iron deficiency is simple and inexpensive especially through the oral route, but may be hampered by some gastrointestinal inconveniences.¹⁵ Several compounds have been added to the standard iron formula in order to enhance iron absorption. Combinations of iron and vitamin C,¹⁶ vitamin A + zinc¹⁷ and taurine¹¹ have been shown to be more effective in restoring hemoglobin levels than iron alone. We designed the present study to estimate the prevalence and possible risk factors of IDA among kindergarten children living in marginalized areas of the Gaza strip and to evaluate the effectiveness of supplementing oral iron formula to ameliorate anemia in these less fortunate IDA children.

Methods

The present work was performed according to a quasi-experimental research design, which includes pre- and post-testing measurements within a treatment group, as well as comparisons between case and control groups for the variables studied.

Study area

The Gaza Strip in Palestine is a narrow piece of land (365 km²) along the East Mediterranean coast divided into five governorates: North, Gaza, Middle, Khan Yunis, and Rafah Governorates. It is considered one of the most populated areas in the world (4583 individuals/km²) with an estimated population of almost 1.7 million according to latest estimates of the Palestinian central bureau of statistics.¹⁸ Nine marginalized (less fortunate for development) areas representing the five governorates of the Gaza strip were involved in the present work. These marginalized areas were identified according to the criteria laid down by the Palestinian Medical Relief Society (PMRS). The studied population comprised all kindergarten children (4-5 years of age) living in the marginalized areas of the Gaza Strip. A total of 735 (384 male and 351 female) randomly selected children were included, they represented the 11 kindergartens located in the nine marginalized areas. A sample size of at least 398 children was calculated for a ± 5% precision level and a 95% confidence level. The sample size was determined based on the population of the marginalized area rather than the governorate population density.

All parts of the study were carried out in accordance to the ethical standards laid down in the 1964 and 1975 Declarations of Helsinki, and the modifications thereafter. All ethical considerations were kept, including respect for the subjects, legitimacy and confidentiality. A signed consent form was obtained from the parents or guardians providing their acceptance and full understanding of the study stages and intervention.

Study stages

The study included three stages. The first stage was assigned to screening for IDA, the second stage was the intervention to correct anemia, and the last stage was the follow up and re-evaluation of the treated children.

Part of the data was collected using a close-ended questionnaire, constructed in the Arabic language, and the data was collected through home visits and direct interviews with the parents or guardians. The questionnaire included major items about sociodemographic and general characteristics, as well as items about the health status and health complaints of the children as addressed by their parents or guardians.

Venous blood samples (2.5 mL in K3-EDTA) were collected from the children, and a complete blood count (CBC) analysis was performed using a Cell Dyne 1700 electronic counter (Sequoia-Turner Corporation, Santa Clara, CA).

Diagnosis of iron deficiency anemia

In the present work, and due to the limited financial and laboratory resources in the marginalized areas, IDA was considered in the microcytic (MCV < 80fl) children using the Mentzer index MCV/RBC > 13^19,20 concomitant to reduced hemoglobin concentration < 11 g/dL for 4-year-old children, and < 11.5 g/dL for 5-year-old children.²¹ The prevalence of IDA was calculated by dividing the number of occurrences of IDA in the randomly selected children by the total number of children.

Replenishing the iron stores and correction of anemia

All children considered as IDA were treated with oral iron supplements (Ferrolet syrup [50 mg ferrous carbonate + 100 mg vitamin C /5mL]) for three months. The dose was calculated based on the child's weight according to standard protocols.²² The iron treatment was under full supervision and guidance of pediatricians at the PMRS.

Post-treatment evaluation

All IDA children who had been treated with oral iron supplements were checked for the same parameters of CBC three months after start of the treatment.

Statistical analysis

Descriptive, frequencies, central tendency, dispersion measurements, cross tabulation and statistical tests included independent and paired t-tests, chi-square, and correlations used to clarify relationships between the studied variables. The associations between anemia and the variables were tested using a simple univariate logistic regression and reported as crude odds ratios (OR) with 95% CI. Statistically predictive variables at the univariate analysis were included in the multiple logistic regression models to examine the risk factors that were potentially associated with anemia in the children living in marginalized areas. The results from the multiple logistic regressions are presented as adjusted odds ratio (aORs) with 95% CI. P-values were two sided and a p-value < 0.05 was considered to indicate statistical significance. All analyses were performed using the IBM SPSS Statistical software (version 18, IBM Corporation, Somers, NY).

Results

The study was conducted on 735 children (384 male & 351 female) representing 11 kindergartens from nine marginalized areas of the five governorates of the Gaza strip. General characteristics of the study population are outlined in Table 1. The overall prevalence of IDA was 33.5% (246/735) with no significant difference (p-value = 0.348) between boys 35.2% (135/384) and girls 31.6% (111/351). Significantly different prevalences of IDA were reported between different governorates, with the highest values reported in the Rafah (108/262; 41.2%) and Middle (38/105; 36.2%) Governorates. Also significantly higher prevalences (p-value = 0.008) were reported among children residing in refugee camps (51/110; 46.4%) compared to rural (94/304; 30.9%) and urban (101/321; 31.5%) areas. Meanwhile, the citizenship status, citizen vs refugee, was not a significant risk factor for IDA (p-value = 0.556; OR= 1.1; 95% CI, 0.796-1.549).

Table 1
- General characteristics of the study population.

Variables	IDA n = 246 n (%)	Control n = 48 n (%)	Odds Ratio (95% CI)	p-value (chi-square)
Gender
Male	135 (54.9)	249 (50.9)	1.172 (0.862-1.6)	0.348 (1.028)
Female	111 (45.1)	240 (49.1)
Governorate
Rafah	108 (43.9)	154 (31.5)	1.702 (1.24 -2.34)	< 0.001 (24.3)
Khan Yunis	23 (9.3)	113 (23.1)	0.343 (0.213-0.553)
Middle	38 (15.5)	67 (13.7)	1.151 (0.748-1.77)
North	56 (22.8)	110 (22.5)	1.016 (0.704-1.464)
Gaza	21 (8.5)	45 (9.2)	1
Residency
City	101 (41.1)	220 (45.0)	0.852 (0.625-1.162)	0.344 (1.029)
Rural and refugee camps	145 (58.9)	269 (55.0)
Citizenship
Refugee	173 (70.3)	333 (68.1)	1.1 (0.796-1.54)	0.556 (0.538)
Local citizen	73 (29.7)	156 (31.9)

• ^IDA
  : iron deficiency anemia
• ^{95% CI}
  : 95% confidence interval

Some of the parents' characteristics are presented in Table 2. The education of the father and mother were risk factors associated with children developing IDA [OR = 0.624 (95% CI, 0.443-0.881) and OR = 0.606 (95% CI, 0.424-0.866), respectively]. Parental smoking habit was a significant risk factor for IDA among children (OR = 0.580; 95% CI, 0.425-0.790); the percentage of anemic children of smoking fathers (126/311; 40.5%) was significantly higher (p-value = 0.001) than those of non-smoking fathers (120/424, 28.3%). While parents' consanguinity was not found to be a risk factor for IDA (OR = 0.798; 95% CI, 0.587-1.085), the percentage of anemic children of consanguineous parents (126/349, 36.1%) does not differ significantly (p-value = 0.150) from those of non-consanguineous parents (120/266; 31.1%).

Table 2
- Some characteristics of the parents of the study population.

Variables	IDA n (%)	Control n (%)	Odds Ratio (95% CI)	p-value (chi-square)
Father education
University degree	61 (24.8)	169 (34.6)	0.624 (0.443-0.881)	0.007 (7.30)
Secondary school and below	185 (75.2)	320 (65.4)
Governorate
University degree	54 (22.0)	155 (31.7)	0.606 (0.424-0.866)	0.006 (7.6)
Secondary school and below	192 (78.0)	334 (68.3)
Father smokinga
Smoker	126 (51.2)	185 (37.8)	0.580 (0.425-0.790)	0.001 (12.0)
Non-smoker	120 (48.8)	304 (62.2)
Parents consanguinity
Consanguineous	126 (51.2)	223 (45.6)	0.798 (0.587-1.085)	0.150 (2.07)
Non-consanguineous	120 (48.8)	266 (54.4)

• ^IDA
  : iron deficiency anemia
• ^{95% CI}
  : 95% confidence interval.
• ^a
  All mothers were non-smokers

Either pregnancy, birth and lactation (Table 3), nor health (Table 4) characteristics of the children showed any significant association for developing IDA. However, there is a trend towards developing IDA with late weaning. IDA was more prevalent among children suffering from chronic or frequent diarrhea, and those suffering from parasitic infections, but these differences were not significant.

Table 3
- Pregnancy, birth and lactation characteristics.

Variables	IDA n (%)	Control n (%)	Odds Ratio (95% CI)	p-value (chi-square)
Anemia in pregnancy
Anemic	73 (29.7)	118 (24.1)	0.624 (0.443-0.881)	0.007 (7.30)
Non-anemic	173 (70.3)	371 (75.9)
Pregnancy supplements
Received	224 (91.1)	421 (86.1)	0.608 (0.366-1.010)	0.057 (3.8)
Did not receive	22 (8.9)	68 (13.9)
Length of pregnancy
Full term	230 (93.5)	455 (91.0)	1.074 (0.581-1.987)	0.878 (0.052)
Preterm	16 (6.5)	34 (9.0)
Feeding
Breast and formula	214 (87.0)	418 (85.5)	1.136 (0.725-1.77)	0.653 (0.31)
Formula only	32 (13.0)	71 (14.5)
Duration of milk feeding (weaning)
≤ 4 months	5 (2.0)	19 (3.9)	0.513 (0.189-1.391)	0.246 (4.147)
5-8 months	42 (17.1)	101 (20.7)	0.791 (0.531-1.177)
9-12 months	48 (19.5)	101 (20.7)	0.931 (0.634-1.367)
> 12 months	151 (61.4)	268 (54.7)	1

• ^IDA
  : iron deficiency anemia
• ^{95% CI}
  : 95% confidence interval.

Table 4
- Health characteristics of the children.

Variables	IDA n = 246 n (%)	Control n = 489 n (%)	Odds Ratio (95% CI)	p-value (chi-square)
Child malnutritiona	38 (15.4)	88 (18.0)	0.832 (0.549-1.262)	0.408 (0.749)
Diarrhea (frequent or chronic)	22 (8.9)	28 (5.7)	0.618 (0.346-1.105)	0.120 (2.672)
Parasitic infections	105 (42.7)	198 (40.5)	0.914 (0.670-1.246)	0.569 (0.325)

• ^IDA
  : iron deficiency anemia
• ^{95% CI}
  : 95% confidence interval.
• ^a
  Child malnutrition was calculated according to the World Health Organization Child Growth Standards 2006 and measuring and interpreting malnutrition and mortality with Weight-for-length Z-score < -2.

The anthropometric characteristics of the children revealed a lower weight and a shorter stature in the IDA group compared to normal controls (15.49 ± 2.29 vs. 16.26 ± 6.55 kg and 103.61 ± 5.42 vs. 105.01 ± 5.14 cm, respectively). Correlation coefficient analysis revealed a significant correlation between hemoglobin concentration and the child's weight (p-value = 0.039) and height (p-value = 0.001) but not with age (p-value = 0.06).

We performed a univariate statistical analysis to study the association between the various exposures, if any, with the anemic state (anemic versus non-anemic controls). In this unadjusted analysis, we calculated the crude ORs and their 95% CI, shown in Tables 1-4. In this analysis, the following factors: governorate, residency, parents' education, and parental smoking showed significant associations with the anemic state. As a result, our multivariate analysis was adjusted to contain fewer potential risk factors. After adjustment of the potential confounding factors, we performed a multivariate statistical analysis in order to calculate the aOR and the 95% CI aiming to identify the possible risk factors associated to anemia in our cohort of Palestinian children living in the marginalized areas. The multiple logistic regression analysis for all cases and controls are presented in Table 5; this analysis highlighted governorate, parents' education and parental smoking as potential risk factors for developing anemia in children living in the marginalized areas of the Gaza Strip.

Table 5
- Univariate (crude OR) multivariate (adjusted OR) analysis for risk factors associated with anemia.

Variable	Univariate	Multivariate
	Crude OR (95% CI)	Adjusted OR (95% CI)
Governorate
Rafah	1.702 (1.24 -2.34)	3.018 (1.709-5.328)
Khan Yunis	0.343 (0.213-0.553)	0.742 (0.488-1.127)
Middle	1.151 (0.748-1.77)	1.160 (0.621-2.168)
North	1.016 (0.704-1.464)	0.991 (0.588-1.673)
Gaza	1	1
Father education	0.624 (0.443-0.881)	0.644 (0.439-0.935)
Mother education	0.606 (0.424-0.866)	0.658 (0.448-0.972)
Father smoking	0.580 (0.425-0.790)	0.574 (0.416-0.793)

• ^OR
  : odds ratio
• ^{95% CI}
  : 95% confidence interval.

Hematological parameters (Table 6) revealed significantly lower CBC values, except for WBC, in IDA children compared to the non-anemic controls. The reduction in hemoglobin and hematocrit levels in the IDA cases were 12.6% and 10.5% compared to controls, but oral iron treatment significantly improved the situation and normalized the IDA markers. After iron treatment, hemoglobin (10.4 ± 0.45 vs. 11.37 ± 0.68 g/dL) and hematocrit (31.34 ± 1.41 vs. 32.63 ± 1.89%) levels were 9.3% and 4.1% higher of the baseline values.

Table 6
- Hematological parameters of the study subjects.

	Controls	Anemic children before treatment	Anemic children after treatment	b p-value Paired sample t- test
	Mean ± SD	Mean ± SD	Mean ± SD
RBC count (× 012/L)	4.49 ± 0.26	4.18 ± 0.45	4.36 ± 0.39	< 0.001
Hemoglobin (g/dL)	11.9 ± 0.40	10.4 ± 0.45	11.37 ± 0.68	< 0.001
Hematocrit (%)	35.02 ± 2.29	31.34 ± 1.41	32.63 ± 1.89	< 0.001
MCV (fl)	78.24 ± 3.43	75.19 ± 7.77	75.19 ± 6.6	0.984
MCH (pg)	26.5 ± 1.8	25.10 ± 2.21	26.26 ± 2.31	< 0.001
MCHC (%)	33.9 ± 1.03	33.17 ± 0.9	34.8 ± 0.69	< 0.001
RDW (%)	12.58 ± 1.00	12.9 ± 1.62	12.80 ± 1.75	0.398
WBC (× 109 /L)a	8.8 ± 2.5	8.5 ± 6.2	8.61 ± 2.86	0.793
PLT (× 109 /L)	355.92 ± 91.52	332.7 ± 96.1	350.95 ± 95.85	0.006

• ^RBC
  : red blood cell
• ^MCV
  : mean corpuscle volume
• ^MCH
  : mean corpuscle
• ^MCHC
  : mean corpuscular hemoglobin concentration
• ^RDW
  : red cell distribution width
• ^WBC
  , white blood cell
• ^PLT
  : platelets
• ^SD
  : standard deviation.
• ^a
  Except for WBC, all means are significantly different between cases and control (independent t-test).
• ^b
  p-value for paired sample t-test for cases before and after treatment.

Discussion

Nutritional deficiencies are very important to the overall health of humans, male and female of all ages, however in some age groups (infants, children, and women in childbearing age) these deficiencies can be critical and the growth and development will be extremely hindered by essential vitamins or nutrients scarcity. Iron deficiency (ID) and IDA are considered to be the most common and prevalent known nutritional disorder of mankind in the world today. Previous studies showed a considerable prevalence of iron deficiency anemia among Palestinians in the Gaza strip.^11,23-25 ID and IDA not only constitute public health nutritional problems, but also their existence with other disorders could interfere with the laboratory and clinical diagnosis of the coexisting disorder.²⁶

We designed the present study that included nine marginalized areas, distributed over the different governorates of Gaza Strip; these areas have attracted little attention from several local and international institutions. Since our target population was the children of the less fortunate marginalized areas, we considered the population in the area for the sampling process, and not the governorate size.

At the screening stage, the presence of IDA was considered in microcytic (MCV < 80fl) children through the Mentzer index MCV/RBC > 13^19,20,27 with accompanying reduced hemoglobin concentration.²¹ The low financial resources and the lack of availability of instruments in the area could be considered as a limitation of the study, justify the use of the Mentzer index for the determination of serum ferritin, deemed essential for this screening. Moreover, the politically restrictive environment in the Gaza strip negatively affects importing medical and laboratory equipment, kits and chemicals to perform laboratory investigations.

The overall prevalence of IDA was 33.5 % with significantly higher prevalences in the Rafah and Middle governorates. Citizenship was not found to be a determinant of IDA, prevalence of IDA was not significantly different between citizens and refugees, concomitant to the national nutritional assessment study performed by Abdeen et al.²³ However, residing in refugee camps is a significant determinant for anemia in our study population. Our results are comparable to the results of Selmi & Al Hindi who reported significantly different prevalences of anemic children between the different regions of the Gaza Strip, Palestine.^23,24

Although, the overall educational background of the children's parents revealed a satisfactory level, low education was a significant risk factor associated with IDA in the children. Parents' education has been considered important in reducing the risk of IDA, and a strong association may exist between a child's health and the educational level of the parents.^28-32 On the other hand, parents' consanguinity was not found to be a risk factor for IDA in the subjects of the present work. While the study of Sirdah reported an association between anemia and parents' consanguinity among adolescent males, no significant difference was observed among females.³³

The anemic status significantly affected the anthropometric characteristics of the young children. The anemic children were found to have a lower mean weight and shorter stature. The effect of anemia during pregnancy on the anthropometric measurements of Saudi newborns was studied by Telatar et al.; the authors revealed a significant negative effect of anemia on neonatal anthropometric measurements.³⁴ The same finding was also reported by Dakshayani, who showed significant decreases in the anthropometric measurements of newborns born to anemic mothers.³⁵ On the other hand, Ayoya et al. considered short stature and stunting as predictors of child anemia.³⁶

The hematological parameters of cases and normal controls indicated significant differences between the two groups in all the CBC values except for WBC; the mean hemoglobin concentration for cases was 12.6 % lower than that in the control group. A remarkable finding of the present work is the success of our intervention to correct the anemic status of the children. The mean values of hematological parameters of the anemic cases before and after treatment revealed statistically significant improvements in most hematological parameters. Bopche et al. reported in Indian children an increase of 10% in hemoglobin concentration after one month of treatment,³⁷ however the mean hemoglobin baseline value of their children was much lower (8.53 g/dL) than that of our study group (10.4 g/dL). In another setting, in Guatemala city, an improvement of 1.8 g/dL in hemoglobin concentration was achieved in infants and young children after 28 days of treatment with ferrous sulfate.³⁸ The superiority of these studies over ours could be due to different factors that include the commitment of the parents and children to the treatment, the coexistence of parasitic infections in the children, compliance with iron therapy and the bioavailability of the iron formula used.^15,22,39

Conclusion

IDA is a serious health problem among the 4- to 5-year-old children living in the less fortunate for development areas of the Gaza strip. Different risk factors for IDA were identified which could be helpful in reducing the prevailing IDA and improving the general health of children. The study justifies the necessity for systematic screening and interventional treatment of anemic children. Other nutritional deficiencies and infectious disorders should be included in future small and large screening studies. The national and international health related organizations working in Palestine should start urgent programs to develop health related programs in these marginalized areas of the Gaza strip, Palestine.

Acknowledgments

The authors would like to thank the Palestinian Medical Relief Society (PMRS) for supporting the present study.

REFERENCES

• ¹
  International Nutritional Anemia Consultative Group (2000) INACG Symposium. 12 March 1999, Durban South Africa, pp. 1-60. ILSI Research Foundation: Washington, DC; 2000.
• ²
  Stoltzfus R. Defining iron-deficiency anemia in public health terms: a time for reflection. J Nutr. 2001;131(2S-2):565S-567S.
• ³
  FAO/WHO. Preventing micronutrient deficiencies. ICN Fact Sheet No. 1. Supporting paper of the International Conference on Nutrition, December 1992, Rome, Italy.
• ⁴
  Steketee RW. Pregnancy, nutrition and parasitic diseases.J Nutr. 2003;133 (5 Suppl 2):1661S-1667S.
• ⁵
  Hashizume M, Kunii O, Sasaki S, Shimoda T, Wakai S, Mazhitova Z, et al. Anemia and iron deficiency among schoolchildren in the Aral Sea region, Kazakhstan. J Trop Pediatr. 2003;49:172-7.
• ⁶
  El-Hioui M, Ahami A, Aboussaleh Y, Rusinek S, Dik K, Soualem A. Iron Deficiency and Anaemia in Rural School Children in a Coastal Area of Morocco. Pakistan J Nutr. 2008;7:400-3.
• ⁷
  Al-Mekhlafi MH, Surin J, Atiya AS, Ariffin WA, Mahdy AK, Abdullah HC. Anaemia and iron deficiency anaemia among aboriginal schoolchildren in rural Peninsular Malaysia: an update on a continuing problem. Trans R Soc Trop Med Hyg. 2008;102:1046-52.
• ⁸
  Gangopadhyay R, Karoshi M, Keith L. Anemia and pregnancy: a link to maternal chronic diseases. Int J Gynaecol Obstet. 2011;115(Suppl 1):S11-5.
• ⁹
  Pasricha SR. Anaemia in pregnancy - not just iron deficiency. Acta Haematol. 2013;130:279-80.
• ¹⁰
  Pasricha SR, Drakesmith H, Black J, Hipgrave D, Biggs BA. Control of iron deficiency anemia in low- and middle-income countries. Blood. 2013;121:2607-17.
• ¹¹
  Sirdah MM, El-Agouza IM, Abu Shahla AN. Possible ameliorative effect of taurine in the treatment of iron-deficiency anaemia in female university students of Gaza, Palestine. Eur J Haematol. 2002;69:236-42.
• ¹²
  World Health Organization, Iron Deficiency Anemia Assessment Prevention and Control: A Guide for Program Managers, World Health Organization, Geneva, Switzerland; 2001.
• ¹³
  Food and Agriculture Organization of the United Nations (FAO).The State of Food Insecurity in the World 6th edition. Rome, Italy; 2004.
• ¹⁴
  Stein AJ, Qaim M. The human and economic cost of hidden hunger.Food Nutr Bull. 2007;28:125-34.
• ¹⁵
  Johnson-Wimbley TD, Graham DY. Diagnosis and management of iron deficiency anemia in the 21st century. Therap Adv Gastroenterol. 2011;4:177-84.
• ¹⁶
  Taniguchi M, Imamura H, Shirota T, Okamatsu H, Fujii Y, Toba M, et al. Improvement in iron deficiency anemia through therapy with ferric ammonium citrate and vitamin C and the effects of aerobic exercise. J Nutr Sci Vitaminol (Tokyo). 1991;37:161-71.
• ¹⁷
  Kolsteren P, Rahman SR, Hilderbrand K, Diniz A. Treatment for iron deficiency anaemia with a combined supplementation of iron, vitamin A and zinc in women of Dinajpur, Bangladesh. Eur J Clin Nutr. 1999;53:102-6.
• ¹⁸
  Palestinian central bureau of statistics(PCBS 2012). Available from: http://www.pcbs.gov.ps/site/512/default.aspx?tabID=512&lang=en&ItemID=788&mid=3171&wversion=Staging
  » Available from: http://www.pcbs.gov.ps/site/512/default.aspx?tabID=512&lang=en&ItemID=788&mid=3171&wversion=Staging
• ¹⁹
  Abelson HT. Complexities in recognizing and treating iron deficiency anemia. Arch PediatrAdolesc Med. 2001;155:332-3.
• ²⁰
  Bogen DL, Krause JP, Serwint JR. Outcome of children identified as anemic by routine screening in an inner-city clinic. Arch Pediatr Adolesc Med. 2001;155:366-71.
• ²¹
  World health Organization (WHO). Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity.Vitamin and Mineral Nutrition Information System.Geneva, World HealthOrganization, 2011 (WHO/NMH/NHD/MNM/11.1).
• ²²
  Stoltzfus RJ, Dreyfuss ML. Guidelines for the use of iron supplements to prevent and treat iron deficiency anemia. Washington: International Nutritional Anemia Consultative Group; 1998.
• ²³
  Abdeen Z, Greenough G, Shahin M, Tayback M. Nutritional Assessment of the West Bank and Gaza Strip. Al-Quds University Publication: Jerusalem, Palestine; 2003.
• ²⁴
  Radi SM, El-Sayed NA, Nofal LM, Abdeen ZA. Ongoing deterioration of the nutritional status of Palestinian preschool children in Gaza under the Israeli siege. East Mediterr Health J. 2013;19:234-41.
• ²⁵
  Selmi A, Al-Hindi A. Anaemia among school children aged 6-11 years old in Gaza Strip, Palestine. Annals of Alquds Medicine. 2011;7:27-32.
• ²⁶
  El-Agouza I, Abu Shahla A, Sirdah M. The effect of iron deficiency anaemia on the levels of haemoglobin subtypes: possible consequences for clinical diagnosis. Clin Lab Haematol. 2002;24:285-9.
• ²⁷
  Sirdah M, Bilto YY, el Jabour S, Najjar K. Screening secondary school students in the Gaza strip for beta-thalassaemia trait. Clin Lab Haematol 1998;20:279-83.
• ²⁸
  Rahman A, Chowdhury S. Determinants of chronic malnutrition among preschool children in Bangladesh. J Biosoc Sci. 2007;39:161-73.
• ²⁹
  Wamani H, Astrøm AN, Peterson S, Tumwine JK, Tylleskär T. Predictors of poor anthropometric status among children under 2 years of age in rural Uganda. Public Health Nutr. 2006;9:320-6.
• ³⁰
  Chopra M. Risk factors for undernutrition of young children in a rural area of South Africa. Public Health Nutr. 2003;6:645-52.
• ³¹
  Choi HJ, Lee HJ, Jang HB, Park JY, Kang JH, Park KH, et al. Effects of maternal education on diet, anemia, and iron deficiency in Korean school-aged children. BMC Public Health. 2011;11:870.
• ³²
  Bharati S, Pal M, Chakrabarty S, Bharati P. Socioeconomic determinants of iron-deficiency anemia among children aged 6 to 59 months in India. Asia Pac J Public Health. 2013 Jul 15 [Epub ahead of print].
• ³³
  Sirdah M. Determinants of hemoglobin level in adolescence students (14-22 years) at Gaza Strip, Palestine. Int J Health Res. 2008;1:225-34.
• ³⁴
  Telatar B, Comert S, Vitrinel A, Erginoz E, Akin Y. The effect of maternal anemia on anthropometric measurements of newborns. Saudi Med J. 2009;30:409-12.
• ³⁵
  Anupama MP, Dakshayani KR. The study of anthropometric measurements of newborn babies in relation to maternal illness. Anatomica Karnataka. 2013;7:67-71.
• ³⁶
  Ayoya MA, Ngnie-Teta I, Séraphin MN, Mamadoultaibou A, Boldon E, Saint-Fleur JE, et al. Prevalence and risk factors of anemia among children 6-59 months old in Haiti. Anemia. 2013;2013:502968.
• ³⁷
  Bopche AV, Dwivedi R, Mishra R, Patel GS. Ferrous sulfate versus iron polymaltose complex for treatment of iron deficiency anemia in children. Indian Pediatr. 2009;46:883-5.
• ³⁸
  Pineda O, Ashmead HD. Effectiveness of treatment of iron-deficiency anemia in infants and young children with ferrous bis-glycinate chelate. Nutrition. 2001;17:381-4.
• ³⁹
  UNICEF/UNU/WHO/MI. Prevention iron deficiency in women and children: Background and consensus on key technical issues and resources for advocacy, planning and implementing national programmes. UNICEF/UNU/WHO/MI Technical Workshop: New York; 1998.

Publication Dates

• Publication in this collection
  Mar-Apr 2014

History

• Received
  03 Oct 2013
• Accepted
  18 Nov 2013